Evidence map›Paper›PMID 29740097›Full record

ArticleScientific reports2018

Impact of

Charlotte Debus, Maria Waltenberger, Ralf Floca, Ali Afshar-Oromieh, Nina Bougatf, Sebastian Adeberg, Sabine Heiland, Martin Bendszus, Wolfgang Wick, Stefan Rieken and 4 more

Abstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Trial
  2. Article
  3. Comparison between [International journal of molecular sciences · 2023
    Article
  4. Synthetic PET via Domain Translation of 3-D MRI.IEEE transactions on radiation and plasma medical sciences · 2023
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Journal of neuro-oncology · 2021
    Article
  10. Minicircles for a two-step blood biomarker and PET imaging early cancer detection strategy.Journal of controlled release : official journal of the Controlled Release Society · 2021
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Charlotte DebusGerman Cancer Consortium (DKTK), Heidelberg, Germany. c.debus@dkfz.de.ORCID 0000-0002-7156-2022
Maria WaltenbergerGerman Cancer Consortium (DKTK), Heidelberg, Germany.
Ralf FlocaDivision of Molecular and Translational Radiation Oncology, Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany.
Ali Afshar-OromiehDepartment of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany.
Nina BougatfDivision of Molecular and Translational Radiation Oncology, Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany.
Sebastian AdebergDivision of Molecular and Translational Radiation Oncology, Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany.
Sabine HeilandDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
Martin BendszusDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
Wolfgang WickGerman Cancer Consortium (DKTK), Heidelberg, Germany.ORCID 0000-0002-6171-634X
Stefan RiekenDivision of Molecular and Translational Radiation Oncology, Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany.
Uwe HaberkornDepartment of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany.
Jürgen DebusGerman Cancer Consortium (DKTK), Heidelberg, Germany.
Maximilian KnollGerman Cancer Consortium (DKTK), Heidelberg, Germany.ORCID 0000-0002-9037-3980
Amir AbdollahiGerman Cancer Consortium (DKTK), Heidelberg, Germany. amir.abdollahi@med.uni-heidelberg.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-precision radiotherapy (HPR) of recurrent high grade glioma (HGG) requires accurate spatial allocation of these infiltrative tumors. We investigated the impact of

Indexed as

Heavy Ion RadiotherapyAdultAgedBrain NeoplasmsDisease ProgressionFemaleFluorodeoxyglucose F18GliomaHumansMagnetic Resonance ImagingMaleMiddle AgedNeoplasm GradingNeoplasm Recurrence, LocalPositron-Emission TomographyPrognosisFluorodeoxyglucose F18

Identifiers

PMID29740097
PMCPMC5940831

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.